Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
Titel:
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
Auteur:
Abou-Alfa, Ghassan K. Yen, Chia-Jui Hsu, Chih-Hung O’Donoghue, Joseph Beylergil, Volkan Ruan, Shutian Pandit-Taskar, Neeta Gansukh, Bolorsukh Lyashchenko, Serge K. Ma, Jennifer Wan, Peter Shao, Yu-Yun Lin, Zhong-Zhe Frenette, Catherine O’Neil, Bert Schwartz, Lawrence Smith-Jones, Peter M. Ohtomo, Toshihiko Tanaka, Takayoshi Morikawa, Hideo Maki, Yuko Ohishi, Norihisa Chen, Ya-Chi Agajanov, Tamara Boisserie, Frederic Laurenzio, Laura Di Lee, Ray Larson, Steven M. Cheng, Ann-Lii Carrasquilo, Jorge A.